Acciones HedgePath Pharmaceuticals Inc
Acciones
US42278K1025
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13/12/22 |
Amy M. McCord
LAW | General Counsel | - | 01/01/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02/08/13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23/08/23 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+32,95 % | 49,46 mil M | |
+2,00 % | 42,58 mil M | |
+49,11 % | 42,49 mil M | |
-4,22 % | 29,09 mil M | |
+12,26 % | 26,61 mil M | |
-23,66 % | 18,64 mil M | |
+8,51 % | 13,16 mil M | |
+30,35 % | 12,55 mil M | |
+24,29 % | 12,1 mil M |